ELECTRONIC PAGES
CASE REPORT
The risk of antimalarials in patients with renal failure
1 Princess Alexandra Hospital, Harlow, Essex, UK
2 The Royal London Hospital, Whitechapel, London, UK
3 Newham University Hospital, London, UK
4 Department of Haematological Oncology, St Bartholomews Hospital, West Smithfield, London, UK
5 St Bartholomews Hospital, West Smithfield, London, UK
6 Department of Haematological Oncology, St Bartholomews Hospital, West Smithfield, London, UK
7 Department of Haematological Oncology, St Bartholomews Hospital, West Smithfield, London, UK
Correspondence to:
Dr S Agrawal, Department of Haematological Oncology, St Bartholomews Hospital, West Smithfield, London EC1A 7BE, UK; s.g.agrawal{at}qmul.ac.uk
We present here a patient with end stage renal failure who received two weeks antimalarial prophylaxis at full dose leading to life threatening toxicity with severe acute megaloblastic anaemia, symptomatic pancytopenia and exfoliative dermatitis. Prompt recognition and treatment can rapidly reverse these fatal effects but more importantly, education of patients before travel is imperative in preventing such events.
Keywords: antimalarials; end stage renal failure; exfoliative dermatitis; megaloblastic anaemia; pancytopenia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
